Naftin’s Comparison Claims Prompt FDA To Draw Conclusions Of Its Own
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA “untitled” letter completes Merz’s sentence, says Naftin’s “Twice as Strong Half as Long” slogan is an unsubstantiated comparison; also, safety data cited on the website is for a different product, agency says.